Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 3.4 Form of Amended and Restated Certificate of Incorporation, to Be Effective Immediately Prior to the Effectiveness of the Registration Statement of Which This Prospectus Forms a Part
- 3.5 Form of Amended and Restated Bylaws, to Be Effective Immediately Prior to the Effectiveness of the Registration Statement of Which This Prospectus Forms a Part
- 4.1 Specimen Stock Certificate Evidencing the Shares of Common Stock
- 10.3 2021 Omnibus Equity Incentive Plan
- 10.7 Employment Agreement by and Between the Company and Shalabh Gupta, M.D., Dated May 18, 2021
- 10.8 Employment Agreement by and Between the Company and Pramod Gupta, M.D., Dated March 22, 2021
- 10.9 Amendment to Employment Agreement by and Between the Company and Pramod Gupta, M.D., Dated April 28, 2021
- 10.10 Master Services Agreement, Dated February 8, 2021, by and Between Unicycive Therapeutics, Inc. and Ascent Development Services, Inc.
- 23.1 Consent of Mayer Hoffman Mccann P.C., Independent Registered Public Accounting Firm
Associated filings
- 14 Jul 21 424B4 Prospectus supplement with pricing info
- 13 Jul 21 EFFECT Notice of effectiveness
- 12 Jul 21 S-1/A IPO registration (amended)
- 12 Jul 21 S-1/A IPO registration (amended)
- 30 Jun 21 S-1/A IPO registration (amended)
- 21 Jun 21 S-1/A IPO registration (amended)
- 7 Jun 21 S-1/A IPO registration (amended)
-
21 May 21 S-1 IPO registration
UNCY similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in this Registration Statement on Form S-1 of our report dated February 18, 2021, with respect to the financial statements of Unicycive Therapeutics, Inc. as of December 31, 2020 and 2019, and for the years then ended (which includes an explanatory paragraph related to the existence of substantial doubt about the Company’s ability to continue as a going concern), and to the reference to us under the heading “Experts” included in this Registration Statement and accompanying prospectus on Form S-1.
/s/ Mayer Hoffman McCann P.C.
San Diego, California
May 21, 2021